IONIS-FB-LRx structure
|
Common Name | IONIS-FB-LRx | ||
|---|---|---|---|---|
| CAS Number | 2272975-74-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IONIS-FB-LRxIONIS-FB-LRx is a specific antisense oligonucleotide (ASO) targeting complement factor B (CFB). IONIS-FB-LRx effectively reduces circulating levels of CFB. IONIS-FB-LRx can be used for geographic atrophy (GA) research[1][2]. |
| Name | IONIS-FB-LRx |
|---|
| Description | IONIS-FB-LRx is a specific antisense oligonucleotide (ASO) targeting complement factor B (CFB). IONIS-FB-LRx effectively reduces circulating levels of CFB. IONIS-FB-LRx can be used for geographic atrophy (GA) research[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Complement factor B (CFB)[1] |
| In Vivo | IONIS-FB-Lrx is administered by subcutaneous injection every four weeks and targets CFB’s hepatic expression[2]. |
| References |
| No Any Chemical & Physical Properties |